Stay updated on Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial

Sign up to get notified when there's something new on the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Regional naming updated and address reformatted to use 'Respublika'; revision upgraded from v3.0.1 to v3.0.2. Minor UI element 'Back to Top' removed.
    Difference
    0.1%
    Check dated 2025-09-13T16:26:21.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page has been updated to include a new research article on the safety profile of Upadacitinib, and the version has been revised from v3.0.0 to v3.0.1.
    Difference
    0.6%
    Check dated 2025-09-06T13:54:40.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of numerous facility names and locations across various countries, while also removing many previously listed locations. This indicates a major restructuring of the content related to geographic information.
    Difference
    18%
    Check dated 2025-08-30T08:35:25.000Z thumbnail image
  4. Check
    130 days ago
    Change Detected
    Summary
    The page has removed an erratum related to the safety profile of upadacitinib in rheumatoid arthritis, which may affect the completeness of the information presented.
    Difference
    0.1%
    Check dated 2025-05-10T13:28:19.000Z thumbnail image
  5. Check
    145 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-04-26T02:43:11.000Z thumbnail image
  6. Check
    152 days ago
    Change Detected
    Summary
    The webpage has undergone significant changes, including the removal of detailed objectives and study design for a clinical trial on rheumatoid arthritis, while adding new information about the interventional model and a revision number.
    Difference
    14%
    Check dated 2025-04-18T19:48:48.000Z thumbnail image

Stay in the know with updates to Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page.